“Optimizing Oral Antiplatelet Therapy in Acute Coronary Syndrome,” approved for 2 hours of continuing pharmacy education (CPE) credit, is now available at the ACCP Web site. This program provides an update on current and emerging antiplatelet therapies for managing ACS. The program’s faculty also discuss issues related to clopidogrel nonresponsiveness, drug interactions with proton pump inhibitors, and laboratory testing of platelet reactivity and patient genotypes. There is no fee for participating in this activity. Click here to link to the program.